These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1994899)

  • 21. beta-Naphthoflavone-inducible cytochrome P4501A1 activity in liver microsomes of the marine safi fish (Siganus canaliculatus).
    Raza H; Otaiba A; Montague W
    Biochem Pharmacol; 1995 Oct; 50(9):1401-6. PubMed ID: 7503790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal.
    Hétu C; Joly JG
    Biochem Pharmacol; 1985 Apr; 34(8):1211-6. PubMed ID: 3873242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the effects of hexachlorobenzene, beta-naphthoflavone, and phenobarbital on cytochrome P-450 and mixed-function oxidases in Japanese quail.
    Carpenter HM; Williams DE; Buhler DR
    J Toxicol Environ Health; 1985; 15(1):93-108. PubMed ID: 3981666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
    Papac DI; Franklin MR
    Drug Metab Dispos; 1988; 16(2):259-64. PubMed ID: 2898344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of amphotericin B treatment duration of hepatic microsomal enzyme function in rats.
    Inselmann G; Voss V; Kunigk F; Heidemann H
    Pharmacology; 1997 Aug; 55(2):87-94. PubMed ID: 9323308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects on rat thyroid function of an hepatic microsomal enzyme inducer.
    Johnson S; McKillop D; Miller J; Smith IK
    Hum Exp Toxicol; 1993 Mar; 12(2):153-8. PubMed ID: 8096714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of aging on hepatic microsomal monooxygenase induction by phenobarbital and beta-naphthoflavone.
    Rikans LE; Notley BA
    Biochem Pharmacol; 1982 Jul; 31(14):2339-43. PubMed ID: 6812588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
    Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
    Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of rodent hepatic drug-metabolizing enzyme activities by the novel anticonvulsant remacemide hydrochloride.
    Riley RJ; Lambert C; Cooper AE; Richmond H; Hall M; Jordan MC; Logan CJ; Clark B
    Drug Metab Dispos; 1995 Sep; 23(9):922-8. PubMed ID: 8565782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New heterocyclic modifiers of oxidative drug metabolism--II. Steric factors in the interaction of isomeric 2-(naphthyl)methylbenzimidazoles with rat hepatic microsomal cytochrome P-450 and monooxygenase activities.
    Murray M
    Biochem Pharmacol; 1987 Feb; 36(4):463-8. PubMed ID: 3493778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for mechanism-based inactivation of rat and chick embryo hepatic cytochrome P4501A and P4503A by dihydropyridines, sydnones, and dihydroquinolines.
    Kimmett SM; McNamee JP; Denofreo RT; Marks GS
    Biochem Pharmacol; 1994 Jun; 47(11):2069-78. PubMed ID: 8010992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of promethazine and isosafrole on rat-hepatic microsomal mono-oxygenase activity: comparison with classic inducers phenobarbitone and beta-naphthoflavone.
    Taylor G; Houston JB; Elcombe CR
    Xenobiotica; 1985 Mar; 15(3):243-9. PubMed ID: 4024659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of microsomal drug metabolizing enzymes by phenobarbitone in the rats exposed to increased environmental temperature.
    Pachecka J; Kobylińska K; Zasłona H; Zagdańska B; Bicz W
    Acta Pol Pharm; 1991; 48(3-4):35-7. PubMed ID: 1669542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of hepatic cytochrome P-450 and xenobiotic metabolizing enzymes in rats gavaged with an Alberta crude oil.
    Khan AA; Coppock RW; Schuler MM; Sharma AK; Lillie LE
    J Toxicol Environ Health; 1989; 28(3):297-307. PubMed ID: 2573735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of rat pulmonary monooxygenase by O,O,S-trimethyl phosphorothioate treatment.
    Imamura T; Gandy J; Fukuto TR
    Biochem Pharmacol; 1983 Nov; 32(21):3191-5. PubMed ID: 6639686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed-function oxidase system induction and propylene hepatotoxicity.
    Osimitz TG; Conolly RB
    J Toxicol Environ Health; 1985; 15(1):39-49. PubMed ID: 2984438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.